Erin LeBlanc to Drug Administration Schedule
This is a "connection" page, showing publications Erin LeBlanc has written about Drug Administration Schedule.
Connection Strength
0.177
-
Risk factors for fracture among current, persistent users of bisphosphonates. Osteoporos Int. 2015 Feb; 26(2):713-25.
Score: 0.123
-
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int. 2013 Feb; 24(2):567-80.
Score: 0.027
-
Vitamin D supplementation and depression in the women's health initiative calcium and vitamin D trial. Am J Epidemiol. 2012 Jul 01; 176(1):1-13.
Score: 0.026